Technical Analysis for PYC - Physiomics Plc
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Resistance | Bearish | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
NR7 | Range Contraction | 13.04% | |
NR7-2 | Range Contraction | 13.04% | |
Narrow Range Bar | Range Contraction | 13.04% | |
NR7 | Range Contraction | 13.04% |
Alert | Time |
---|---|
Possible Pocket Pivot | about 21 hours ago |
Rose Above Upper Bollinger Band | about 22 hours ago |
Rose Above 50 DMA | about 22 hours ago |
Up 1 ATR | about 23 hours ago |
Fell Below Previous Day's Low | about 24 hours ago |
Get this analysis on your stocks daily!
Physiomics Plc Description
Physiomics Plc is engaged in the provision of outsourced systems and computational biology services to pharmaceutical companies. The Company is focused on the development of Virtual Tumour Clinical, to directly predict optimal regimens for human clinical trials; Cardiac tox prediction service, to predict unwanted toxic side effects of drug candidates in the drug discovery process, and Drug combinations database, for researchers and clinicians to access literature data on pre-clinical and clinical regimens and their effects. Its services include Target Validation, Mechanism of Action Studies, Lead Selection, Clinical Pharmacokinetic/Pharmacodynamics (PK/PD), EASYAP/Cardiac Toxicity Service, Virtual Tumour Preclinical and Virtual Tumour Clinical. It offers a services and technology for predicting cardiac toxicity. It also focuses on offering offer Model Based Drug Development (MBDD) services, which include Population PKPD analysis of clinical data and Back-translational analysis.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Pharmaceutical Clinic Biology Pharmaceutical Industry Drug Discovery Clinical Trial Drug Development Health Sciences Omics Translation Validation Dynamics Pharmaceutical Companies Pre Clinical Development
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 3.288 |
52 Week Low | 0.9 |
Average Volume | 438,799 |
200-Day Moving Average | 1.47 |
50-Day Moving Average | 1.33 |
20-Day Moving Average | 1.24 |
10-Day Moving Average | 1.18 |
Average True Range | 0.15 |
RSI (14) | 54.13 |
ADX | 14.6 |
+DI | 26.78 |
-DI | 11.41 |
Chandelier Exit (Long, 3 ATRs) | 1.05 |
Chandelier Exit (Short, 3 ATRs) | 1.52 |
Upper Bollinger Bands | 1.39 |
Lower Bollinger Band | 1.08 |
Percent B (%b) | 0.71 |
BandWidth | 25.13 |
MACD Line | -0.04 |
MACD Signal Line | -0.05 |
MACD Histogram | 0.01 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.75 | ||||
Resistance 3 (R3) | 1.73 | 1.57 | 1.68 | ||
Resistance 2 (R2) | 1.57 | 1.45 | 1.58 | 1.65 | |
Resistance 1 (R1) | 1.43 | 1.38 | 1.50 | 1.45 | 1.62 |
Pivot Point | 1.27 | 1.27 | 1.30 | 1.28 | 1.27 |
Support 1 (S1) | 1.13 | 1.15 | 1.20 | 1.15 | 0.98 |
Support 2 (S2) | 0.97 | 1.08 | 0.98 | 0.95 | |
Support 3 (S3) | 0.83 | 0.97 | 0.93 | ||
Support 4 (S4) | 0.85 |